DGAP-CMS: CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 9th Interim Announcement, concurrently Completion Announcement

2021. április 30., péntek, 07:53







DGAP Post-admission Duties announcement: CompuGroup Medical SE & Co. KGaA


/ Share Buy-Back






CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 9th Interim Announcement, concurrently Completion Announcement








30.04.2021 / 07:53



Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.




Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052



CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 9th Interim Announcement, concurrently Completion Announcement



In the period from April 28, 2021 until and including April 29, 2021, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 5,983 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on February 25, 2021 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on February 26, 2021 and which has been increased and extended as per announcement on March 25, 2021.



The aggregate number of shares bought back each day during the period from April 28, 2021 until and including April 29, 2021 as well as the daily volume-weighted average prices for such buy-backs are as follows:















Date Aggregate volume (number of no-par value shares) Volume-weighted average price (in EUR, excluding ancillary costs and charges)
April 28, 2021 2,983 75.9500
April 29, 2021 3,000 75.9500
Total: 5,983 75.9500

 

The aggregate number of shares bought back within the share buy-back program in the period from February 26, 2021 until and including April 29, 2021 amounts to 1,000,000 shares. The maximum number of shares to be bought back under the share buy-back program has been reached on April 29, 2021 and the share buy-back program is therefore completed. The purchase price per share paid for the 500,000 shares bought up to the increase and extension of the share buy-back program amounted to an average of EUR 69.1251. The purchase price per share paid for the 500,000 shares bought back after the increase and extension of the share buy-back program announced on March 25, 2021 was on average EUR 73.3665. In total, the purchase price per share paid for the 1,000,000 shares repurchased on the stock exchange was EUR 71.2458.



Detailed information about the transactions are published on the company"s website under www.cgm.com/sbb.



The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading).



Koblenz, April 30, 2021



CompuGroup Medical SE & Co. KGaA

The general partner
















30.04.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de













Language: English
Company: CompuGroup Medical SE & Co. KGaA

Maria Trost 21

56070 Koblenz

Germany
Internet: www.cgm.com





 
End of News DGAP News Service





1190924  30.04.2021 



fncls.ssp?fn=show_t_gif&application_id=1190924&application_name=news&site_id=geo_holding_tug
Tilos a hír bármilyen adatbázisba történő mentése vagy annak továbbítása harmadik fél számára;kereskedelmi viszonylatban vagy kereskedelmi céllal csak a Deutsche Gesellschaft für Ad-hoc-Publizität mbh írásos engedélyével történhet.

Közzétételek - archívum